Mike Minakowski Email & Phone Number

Philadelphia, Pa, Us

Recruited by the founder as part of a three member executive team to raise seed money, vet and develop partnerships, collaborate and execute superior sales and marketing strategies and tactics to bring the mHeart product to market. Commercial leader collaborating with customers, vendors and potential partners while building out sales and marketing "go to market strategies" in cardiology and cardio-oncology.Along with the founder, led the initial "form factor trials" and analysis, pre-sub presentation to the FDA, and patent submissions. Additionally, recruited key KOLs, HCPs advisors and BoD members.• Raised in excess of $ 1 M in seed money in 6 months• Selected developer and oversaw the build out and launch of the DRS.LINQ website• Led trade show strategy and execution for angel investor’s conference (developed the marketing and sales messaging, trained staff and executed pre-, in- and post-show strategies and tactics• Developed partnerships with KOLs and healthcare facilities for clinical trial opportunities as well as with manufacturing, financial, engineering and healthcare professionals

Amsterdam, Noord-Holland, Nl

Entrepreneurial lead responsible for creating and executing innovative strategies and tactics to support sales growth through the integration of Biotelemetry and Philips. Team leader creating structure, depth and capabilities across the marketing department to ensure continuity and consistency of success in achieving KPIs.• Full P&L responsibility• IDN Strategy for Clinical Care Pathways including TAVR, ED discharge, Stroke and AF Ablation• Trade show strategy and execution including KOL speaker programs • Developed marketing messaging for sales training for NSM and throughout the year• Product marketing manager for Saas and extended wear Holter (EWH) lines• SEA and SEO to drive organic growth and new business using selected key words and specific platforms

Hamilton, Nj, Us

Developed and implemented sales, marketing and business development strategies and tactics to revitalize and reinvigorate the company, brand, and customer base. Sought out the voice of the customer to tailor key marketing and sales messaging focusing on infection control across multiple platforms using both print and digital. Created value proposition that engaged all key stakeholders. Among the targets were infection control directors, purchasing, C-suite and HCPs in hospitals, dialysis clinics, urgent care centers, long-term care facilities and ambulatory care.Transformed the sales and marketing department to turn around company sales after 4 years of accelerating losses. Drove increasingly higher percentage sales growth for 3+ years while improving EBITDA (28%, 29.8% and 30.3%) with limited resources. Grew dialysis sales 28% in first year while achieving 60% market share by Q1 2019. Q1 2020 sales are the best quarter in company history. Lead presenter to PE acquisition prospects. As a two-person executive team (with the president), represented the shareholders and sold company to private equity in Q2 of 2019. Secured above market multiple. Identified, onboarded, and collaborated with an external agency to develop and implement original qualitative and quantitative research to create a roadmap to achieve the next level of growth. Research focused on both HCPs and consumers. Based on the results, rewrote all print (sales collateral), on-line and social media content. Overhauled and relaunched corporate and consumer websites. Launched products on Amazon and Wal-Mart.com which produced unprecedented (on-going) top-line and margin growth.

Jersey City, Nj, Us

Member of the Executive Committee whose role was to develop the policies and direction of the association to become more inclusive and influential in the IVD marketplace. Also, developed financial plans for the association. Chair, Membership Committee.

Led strategic planning initiatives and new business development with P&L responsibility.

Represented and collaborated with the world's leading medical and healthcare associations (e.g., The Endocrine Society, the American Society of Nephrology and the AACC) to strategically plan, market and sell association value to the pharmaceutical, medical device and healthcare companies. Produced yearly double digit growth over a 20 year period. Grew the AACC exhibition exponentially to become the world largest, most-admired IVD show.New business development efforts yielded significant additional customers including ASCP and AMCP that contributed more than $1 million dollars in sales annually. Additionally, organic growth was achieved by adding innovative products that were developed internally and externally.

Education record

Bs, Life Sciences (Pre-Med Track)